nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—AR—type 2 diabetes mellitus	0.197	0.483	CbGaD
Mifepristone—NR3C1—type 2 diabetes mellitus	0.134	0.327	CbGaD
Mifepristone—CYP3A4—type 2 diabetes mellitus	0.0775	0.19	CbGaD
Mifepristone—ABCC1—Glyburide—type 2 diabetes mellitus	0.0357	0.0963	CbGbCtD
Mifepristone—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0261	0.0705	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0261	0.0705	CbGbCtD
Mifepristone—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0261	0.0705	CbGbCtD
Mifepristone—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0233	0.0628	CbGbCtD
Mifepristone—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0196	0.0529	CbGbCtD
Mifepristone—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0168	0.0454	CbGbCtD
Mifepristone—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0159	0.0428	CbGbCtD
Mifepristone—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0156	0.0422	CbGbCtD
Mifepristone—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0146	0.0395	CbGbCtD
Mifepristone—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0139	0.0376	CbGbCtD
Mifepristone—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0128	0.0344	CbGbCtD
Mifepristone—CYP3A5—Losartan—type 2 diabetes mellitus	0.0121	0.0327	CbGbCtD
Mifepristone—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.012	0.0324	CbGbCtD
Mifepristone—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0116	0.0312	CbGbCtD
Mifepristone—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0115	0.0311	CbGbCtD
Mifepristone—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0112	0.0301	CbGbCtD
Mifepristone—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0101	0.0272	CbGbCtD
Mifepristone—ABCB1—Glyburide—type 2 diabetes mellitus	0.00862	0.0232	CbGbCtD
Mifepristone—ABCB1—Losartan—type 2 diabetes mellitus	0.00788	0.0213	CbGbCtD
Mifepristone—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00764	0.0206	CbGbCtD
Mifepristone—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00733	0.0198	CbGbCtD
Mifepristone—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00733	0.0198	CbGbCtD
Mifepristone—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00693	0.0187	CbGbCtD
Mifepristone—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00516	0.0139	CbGbCtD
Mifepristone—CYP3A4—Losartan—type 2 diabetes mellitus	0.00472	0.0127	CbGbCtD
Mifepristone—AR—penis—type 2 diabetes mellitus	0.00225	0.144	CbGeAlD
Mifepristone—PGR—artery—type 2 diabetes mellitus	0.00131	0.0839	CbGeAlD
Mifepristone—NR3C1—nerve—type 2 diabetes mellitus	0.000748	0.048	CbGeAlD
Mifepristone—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.00071	0.0456	CbGeAlD
Mifepristone—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.000608	0.039	CbGeAlD
Mifepristone—CYP3A7—liver—type 2 diabetes mellitus	0.000464	0.0298	CbGeAlD
Mifepristone—PGR—cardiovascular system—type 2 diabetes mellitus	0.000454	0.0292	CbGeAlD
Mifepristone—PGR—adipose tissue—type 2 diabetes mellitus	0.0004	0.0257	CbGeAlD
Mifepristone—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.000395	0.0253	CbGeAlD
Mifepristone—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000365	0.0234	CbGeAlD
Mifepristone—NR3C1—islet of Langerhans—type 2 diabetes mellitus	0.000362	0.0233	CbGeAlD
Mifepristone—AR—cardiovascular system—type 2 diabetes mellitus	0.000362	0.0232	CbGeAlD
Mifepristone—AR—kidney—type 2 diabetes mellitus	0.000354	0.0227	CbGeAlD
Mifepristone—AR—cortex of kidney—type 2 diabetes mellitus	0.000345	0.0221	CbGeAlD
Mifepristone—ABCC1—cortex of kidney—type 2 diabetes mellitus	0.000327	0.021	CbGeAlD
Mifepristone—AR—adipose tissue—type 2 diabetes mellitus	0.000319	0.0205	CbGeAlD
Mifepristone—ABCC1—adipose tissue—type 2 diabetes mellitus	0.000303	0.0195	CbGeAlD
Mifepristone—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000294	0.0189	CbGeAlD
Mifepristone—NR3C1—nephron tubule—type 2 diabetes mellitus	0.000292	0.0187	CbGeAlD
Mifepristone—NR3C1—cardiovascular system—type 2 diabetes mellitus	0.000262	0.0168	CbGeAlD
Mifepristone—CYP3A5—kidney—type 2 diabetes mellitus	0.000258	0.0166	CbGeAlD
Mifepristone—CYP3A5—pancreas—type 2 diabetes mellitus	0.000257	0.0165	CbGeAlD
Mifepristone—NR3C1—kidney—type 2 diabetes mellitus	0.000256	0.0165	CbGeAlD
Mifepristone—NR3C1—pancreas—type 2 diabetes mellitus	0.000255	0.0164	CbGeAlD
Mifepristone—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000252	0.0162	CbGeAlD
Mifepristone—NR3C1—cortex of kidney—type 2 diabetes mellitus	0.00025	0.016	CbGeAlD
Mifepristone—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000233	0.015	CbGeAlD
Mifepristone—NR3C1—adipose tissue—type 2 diabetes mellitus	0.000231	0.0148	CbGeAlD
Mifepristone—AR—liver—type 2 diabetes mellitus	0.000224	0.0144	CbGeAlD
Mifepristone—ABCC1—liver—type 2 diabetes mellitus	0.000213	0.0136	CbGeAlD
Mifepristone—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000194	0.0125	CbGeAlD
Mifepristone—CYP3A4—kidney—type 2 diabetes mellitus	0.000194	0.0124	CbGeAlD
Mifepristone—CYP2D6—kidney—type 2 diabetes mellitus	0.000191	0.0123	CbGeAlD
Mifepristone—ABCB1—retina—type 2 diabetes mellitus	0.000166	0.0106	CbGeAlD
Mifepristone—CYP3A5—liver—type 2 diabetes mellitus	0.000163	0.0105	CbGeAlD
Mifepristone—NR3C1—liver—type 2 diabetes mellitus	0.000162	0.0104	CbGeAlD
Mifepristone—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000156	0.01	CbGeAlD
Mifepristone—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.00014	0.00901	CbGeAlD
Mifepristone—ABCB1—kidney—type 2 diabetes mellitus	0.000137	0.00881	CbGeAlD
Mifepristone—ABCB1—pancreas—type 2 diabetes mellitus	0.000136	0.00875	CbGeAlD
Mifepristone—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000134	0.00858	CbGeAlD
Mifepristone—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000134	0.00094	CcSEcCtD
Mifepristone—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000134	0.000939	CcSEcCtD
Mifepristone—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000133	0.000938	CcSEcCtD
Mifepristone—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000133	0.000937	CcSEcCtD
Mifepristone—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000133	0.000937	CcSEcCtD
Mifepristone—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000133	0.000936	CcSEcCtD
Mifepristone—Hypertension—Metformin—type 2 diabetes mellitus	0.000132	0.000931	CcSEcCtD
Mifepristone—Urticaria—Glyburide—type 2 diabetes mellitus	0.000132	0.000931	CcSEcCtD
Mifepristone—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000132	0.00093	CcSEcCtD
Mifepristone—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000132	0.00093	CcSEcCtD
Mifepristone—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000132	0.000928	CcSEcCtD
Mifepristone—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000132	0.000927	CcSEcCtD
Mifepristone—Back pain—Losartan—type 2 diabetes mellitus	0.000132	0.000927	CcSEcCtD
Mifepristone—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000132	0.000926	CcSEcCtD
Mifepristone—Anorexia—Valsartan—type 2 diabetes mellitus	0.000131	0.000922	CcSEcCtD
Mifepristone—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000131	0.000921	CcSEcCtD
Mifepristone—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000131	0.00092	CcSEcCtD
Mifepristone—Myalgia—Metformin—type 2 diabetes mellitus	0.000131	0.000919	CcSEcCtD
Mifepristone—Malaise—Irbesartan—type 2 diabetes mellitus	0.000131	0.000918	CcSEcCtD
Mifepristone—Headache—Pioglitazone—type 2 diabetes mellitus	0.00013	0.000914	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.00013	0.000912	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000129	0.000909	CcSEcCtD
Mifepristone—Discomfort—Metformin—type 2 diabetes mellitus	0.000129	0.000907	CcSEcCtD
Mifepristone—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000129	0.000907	CcSEcCtD
Mifepristone—Nausea—Glipizide—type 2 diabetes mellitus	0.000129	0.000905	CcSEcCtD
Mifepristone—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000129	0.000904	CcSEcCtD
Mifepristone—Hypotension—Valsartan—type 2 diabetes mellitus	0.000129	0.000903	CcSEcCtD
Mifepristone—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000128	0.000901	CcSEcCtD
Mifepristone—Pain—Gliclazide—type 2 diabetes mellitus	0.000128	0.0009	CcSEcCtD
Mifepristone—Constipation—Gliclazide—type 2 diabetes mellitus	0.000128	0.0009	CcSEcCtD
Mifepristone—Rash—Glimepiride—type 2 diabetes mellitus	0.000127	0.000896	CcSEcCtD
Mifepristone—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000127	0.000895	CcSEcCtD
Mifepristone—Rash—Sitagliptin—type 2 diabetes mellitus	0.000127	0.000893	CcSEcCtD
Mifepristone—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000127	0.000892	CcSEcCtD
Mifepristone—Headache—Glimepiride—type 2 diabetes mellitus	0.000127	0.00089	CcSEcCtD
Mifepristone—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000126	0.000889	CcSEcCtD
Mifepristone—Headache—Sitagliptin—type 2 diabetes mellitus	0.000126	0.000887	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000125	0.000881	CcSEcCtD
Mifepristone—Oedema—Metformin—type 2 diabetes mellitus	0.000125	0.000881	CcSEcCtD
Mifepristone—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000125	0.000879	CcSEcCtD
Mifepristone—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000125	0.000877	CcSEcCtD
Mifepristone—Angioedema—Losartan—type 2 diabetes mellitus	0.000125	0.000876	CcSEcCtD
Mifepristone—Infection—Metformin—type 2 diabetes mellitus	0.000124	0.000875	CcSEcCtD
Mifepristone—Insomnia—Valsartan—type 2 diabetes mellitus	0.000124	0.000875	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000124	0.00087	CcSEcCtD
Mifepristone—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000124	0.00794	CbGeAlD
Mifepristone—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000123	0.000867	CcSEcCtD
Mifepristone—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000123	0.000867	CcSEcCtD
Mifepristone—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000123	0.000867	CcSEcCtD
Mifepristone—Insomnia—Orlistat—type 2 diabetes mellitus	0.000123	0.000864	CcSEcCtD
Mifepristone—Malaise—Losartan—type 2 diabetes mellitus	0.000123	0.000864	CcSEcCtD
Mifepristone—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000123	0.000864	CcSEcCtD
Mifepristone—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000123	0.000863	CcSEcCtD
Mifepristone—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000123	0.000863	CcSEcCtD
Mifepristone—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000123	0.000862	CcSEcCtD
Mifepristone—CYP3A4—liver—type 2 diabetes mellitus	0.000123	0.00787	CbGeAlD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000122	0.000861	CcSEcCtD
Mifepristone—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000122	0.000861	CcSEcCtD
Mifepristone—Somnolence—Valsartan—type 2 diabetes mellitus	0.000122	0.00086	CcSEcCtD
Mifepristone—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000122	0.000856	CcSEcCtD
Mifepristone—Skin disorder—Metformin—type 2 diabetes mellitus	0.000122	0.000855	CcSEcCtD
Mifepristone—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000121	0.000851	CcSEcCtD
Mifepristone—CYP2D6—liver—type 2 diabetes mellitus	0.000121	0.00774	CbGeAlD
Mifepristone—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000121	0.000848	CcSEcCtD
Mifepristone—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000121	0.000848	CcSEcCtD
Mifepristone—Nausea—Glimepiride—type 2 diabetes mellitus	0.00012	0.000844	CcSEcCtD
Mifepristone—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00012	0.000841	CcSEcCtD
Mifepristone—Asthenia—Glyburide—type 2 diabetes mellitus	0.00012	0.000841	CcSEcCtD
Mifepristone—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.00012	0.000841	CcSEcCtD
Mifepristone—Anorexia—Metformin—type 2 diabetes mellitus	0.000119	0.000839	CcSEcCtD
Mifepristone—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000119	0.000836	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000119	0.000835	CcSEcCtD
Mifepristone—Fatigue—Valsartan—type 2 diabetes mellitus	0.000119	0.000834	CcSEcCtD
Mifepristone—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000118	0.000832	CcSEcCtD
Mifepristone—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000118	0.000832	CcSEcCtD
Mifepristone—Oedema—Irbesartan—type 2 diabetes mellitus	0.000118	0.000831	CcSEcCtD
Mifepristone—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000118	0.000831	CcSEcCtD
Mifepristone—Pruritus—Glyburide—type 2 diabetes mellitus	0.000118	0.000829	CcSEcCtD
Mifepristone—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000118	0.000827	CcSEcCtD
Mifepristone—Constipation—Valsartan—type 2 diabetes mellitus	0.000118	0.000827	CcSEcCtD
Mifepristone—Infection—Irbesartan—type 2 diabetes mellitus	0.000117	0.000826	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000117	0.000825	CcSEcCtD
Mifepristone—Fatigue—Orlistat—type 2 diabetes mellitus	0.000117	0.000824	CcSEcCtD
Mifepristone—Hypotension—Metformin—type 2 diabetes mellitus	0.000117	0.000823	CcSEcCtD
Mifepristone—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000117	0.000822	CcSEcCtD
Mifepristone—Pain—Orlistat—type 2 diabetes mellitus	0.000116	0.000817	CcSEcCtD
Mifepristone—Arthralgia—Losartan—type 2 diabetes mellitus	0.000116	0.000816	CcSEcCtD
Mifepristone—Myalgia—Losartan—type 2 diabetes mellitus	0.000116	0.000816	CcSEcCtD
Mifepristone—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000116	0.000815	CcSEcCtD
Mifepristone—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000116	0.000815	CcSEcCtD
Mifepristone—Anxiety—Losartan—type 2 diabetes mellitus	0.000116	0.000813	CcSEcCtD
Mifepristone—Rash—Bromocriptine—type 2 diabetes mellitus	0.000115	0.000808	CcSEcCtD
Mifepristone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000115	0.000808	CcSEcCtD
Mifepristone—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000115	0.000807	CcSEcCtD
Mifepristone—Discomfort—Losartan—type 2 diabetes mellitus	0.000115	0.000806	CcSEcCtD
Mifepristone—Headache—Bromocriptine—type 2 diabetes mellitus	0.000114	0.000803	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000114	0.000802	CcSEcCtD
Mifepristone—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000114	0.000802	CcSEcCtD
Mifepristone—Dry mouth—Losartan—type 2 diabetes mellitus	0.000113	0.000798	CcSEcCtD
Mifepristone—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000113	0.000792	CcSEcCtD
Mifepristone—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000112	0.000791	CcSEcCtD
Mifepristone—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000112	0.00079	CcSEcCtD
Mifepristone—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000112	0.000787	CcSEcCtD
Mifepristone—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000112	0.000785	CcSEcCtD
Mifepristone—Somnolence—Metformin—type 2 diabetes mellitus	0.000111	0.000783	CcSEcCtD
Mifepristone—Oedema—Losartan—type 2 diabetes mellitus	0.000111	0.000782	CcSEcCtD
Mifepristone—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000111	0.000781	CcSEcCtD
Mifepristone—Infection—Losartan—type 2 diabetes mellitus	0.000111	0.000777	CcSEcCtD
Mifepristone—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00011	0.000776	CcSEcCtD
Mifepristone—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00011	0.000775	CcSEcCtD
Mifepristone—Urticaria—Valsartan—type 2 diabetes mellitus	0.000109	0.000768	CcSEcCtD
Mifepristone—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000109	0.000767	CcSEcCtD
Mifepristone—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000109	0.000765	CcSEcCtD
Mifepristone—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000109	0.000764	CcSEcCtD
Mifepristone—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000108	0.000762	CcSEcCtD
Mifepristone—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000108	0.000762	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000108	0.00076	CcSEcCtD
Mifepristone—Fatigue—Metformin—type 2 diabetes mellitus	0.000108	0.000759	CcSEcCtD
Mifepristone—Urticaria—Orlistat—type 2 diabetes mellitus	0.000108	0.000759	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000108	0.000757	CcSEcCtD
Mifepristone—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000107	0.000755	CcSEcCtD
Mifepristone—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000107	0.000755	CcSEcCtD
Mifepristone—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000107	0.000755	CcSEcCtD
Mifepristone—Constipation—Metformin—type 2 diabetes mellitus	0.000107	0.000753	CcSEcCtD
Mifepristone—Angioedema—Ramipril—type 2 diabetes mellitus	0.000107	0.000751	CcSEcCtD
Mifepristone—Anorexia—Losartan—type 2 diabetes mellitus	0.000106	0.000745	CcSEcCtD
Mifepristone—Vomiting—Glyburide—type 2 diabetes mellitus	0.000106	0.000745	CcSEcCtD
Mifepristone—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000106	0.000745	CcSEcCtD
Mifepristone—Malaise—Ramipril—type 2 diabetes mellitus	0.000105	0.000741	CcSEcCtD
Mifepristone—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000105	0.000741	CcSEcCtD
Mifepristone—Rash—Glyburide—type 2 diabetes mellitus	0.000105	0.000739	CcSEcCtD
Mifepristone—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000105	0.000739	CcSEcCtD
Mifepristone—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000105	0.000738	CcSEcCtD
Mifepristone—Headache—Glyburide—type 2 diabetes mellitus	0.000104	0.000734	CcSEcCtD
Mifepristone—Hypotension—Losartan—type 2 diabetes mellitus	0.000104	0.000731	CcSEcCtD
Mifepristone—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000103	0.000726	CcSEcCtD
Mifepristone—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000103	0.000722	CcSEcCtD
Mifepristone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000102	0.00072	CcSEcCtD
Mifepristone—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000102	0.00072	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000102	0.000717	CcSEcCtD
Mifepristone—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000102	0.000716	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000101	0.000712	CcSEcCtD
Mifepristone—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000101	0.000712	CcSEcCtD
Mifepristone—Pain—Irbesartan—type 2 diabetes mellitus	0.000101	0.000711	CcSEcCtD
Mifepristone—Constipation—Irbesartan—type 2 diabetes mellitus	0.000101	0.000711	CcSEcCtD
Mifepristone—Insomnia—Losartan—type 2 diabetes mellitus	0.000101	0.000707	CcSEcCtD
Mifepristone—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.0001	0.000704	CcSEcCtD
Mifepristone—Urticaria—Metformin—type 2 diabetes mellitus	9.95e-05	0.000699	CcSEcCtD
Mifepristone—Myalgia—Ramipril—type 2 diabetes mellitus	9.95e-05	0.000699	CcSEcCtD
Mifepristone—Arthralgia—Ramipril—type 2 diabetes mellitus	9.95e-05	0.000699	CcSEcCtD
Mifepristone—Dyspnoea—Losartan—type 2 diabetes mellitus	9.92e-05	0.000697	CcSEcCtD
Mifepristone—Anxiety—Ramipril—type 2 diabetes mellitus	9.92e-05	0.000697	CcSEcCtD
Mifepristone—Nausea—Glyburide—type 2 diabetes mellitus	9.9e-05	0.000696	CcSEcCtD
Mifepristone—Abdominal pain—Metformin—type 2 diabetes mellitus	9.9e-05	0.000696	CcSEcCtD
Mifepristone—Dizziness—Gliclazide—type 2 diabetes mellitus	9.9e-05	0.000696	CcSEcCtD
Mifepristone—Somnolence—Losartan—type 2 diabetes mellitus	9.89e-05	0.000695	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	9.88e-05	0.000695	CcSEcCtD
Mifepristone—Asthenia—Valsartan—type 2 diabetes mellitus	9.87e-05	0.000694	CcSEcCtD
Mifepristone—Discomfort—Ramipril—type 2 diabetes mellitus	9.83e-05	0.000691	CcSEcCtD
Mifepristone—Asthenia—Orlistat—type 2 diabetes mellitus	9.75e-05	0.000685	CcSEcCtD
Mifepristone—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	9.74e-05	0.000685	CcSEcCtD
Mifepristone—Pruritus—Valsartan—type 2 diabetes mellitus	9.73e-05	0.000684	CcSEcCtD
Mifepristone—Dry mouth—Ramipril—type 2 diabetes mellitus	9.73e-05	0.000684	CcSEcCtD
Mifepristone—Decreased appetite—Losartan—type 2 diabetes mellitus	9.67e-05	0.00068	CcSEcCtD
Mifepristone—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	9.67e-05	0.000679	CcSEcCtD
Mifepristone—Pruritus—Orlistat—type 2 diabetes mellitus	9.62e-05	0.000676	CcSEcCtD
Mifepristone—Fatigue—Losartan—type 2 diabetes mellitus	9.59e-05	0.000674	CcSEcCtD
Mifepristone—Oedema—Ramipril—type 2 diabetes mellitus	9.54e-05	0.000671	CcSEcCtD
Mifepristone—Vomiting—Gliclazide—type 2 diabetes mellitus	9.52e-05	0.000669	CcSEcCtD
Mifepristone—Pain—Losartan—type 2 diabetes mellitus	9.51e-05	0.000669	CcSEcCtD
Mifepristone—Constipation—Losartan—type 2 diabetes mellitus	9.51e-05	0.000669	CcSEcCtD
Mifepristone—Rash—Gliclazide—type 2 diabetes mellitus	9.44e-05	0.000664	CcSEcCtD
Mifepristone—Dermatitis—Gliclazide—type 2 diabetes mellitus	9.43e-05	0.000663	CcSEcCtD
Mifepristone—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.41e-05	0.000662	CcSEcCtD
Mifepristone—Urticaria—Irbesartan—type 2 diabetes mellitus	9.39e-05	0.00066	CcSEcCtD
Mifepristone—Headache—Gliclazide—type 2 diabetes mellitus	9.38e-05	0.000659	CcSEcCtD
Mifepristone—Nervous system disorder—Ramipril—type 2 diabetes mellitus	9.35e-05	0.000658	CcSEcCtD
Mifepristone—Body temperature increased—Irbesartan—type 2 diabetes mellitus	9.34e-05	0.000657	CcSEcCtD
Mifepristone—Abdominal pain—Irbesartan—type 2 diabetes mellitus	9.34e-05	0.000657	CcSEcCtD
Mifepristone—Diarrhoea—Orlistat—type 2 diabetes mellitus	9.3e-05	0.000654	CcSEcCtD
Mifepristone—Skin disorder—Ramipril—type 2 diabetes mellitus	9.26e-05	0.000651	CcSEcCtD
Mifepristone—Feeling abnormal—Losartan—type 2 diabetes mellitus	9.17e-05	0.000644	CcSEcCtD
Mifepristone—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	9.1e-05	0.000639	CcSEcCtD
Mifepristone—Dizziness—Valsartan—type 2 diabetes mellitus	9.1e-05	0.000639	CcSEcCtD
Mifepristone—Anorexia—Ramipril—type 2 diabetes mellitus	9.09e-05	0.000639	CcSEcCtD
Mifepristone—Dizziness—Orlistat—type 2 diabetes mellitus	8.99e-05	0.000632	CcSEcCtD
Mifepristone—Asthenia—Metformin—type 2 diabetes mellitus	8.99e-05	0.000632	CcSEcCtD
Mifepristone—Hypotension—Ramipril—type 2 diabetes mellitus	8.91e-05	0.000627	CcSEcCtD
Mifepristone—Nausea—Gliclazide—type 2 diabetes mellitus	8.89e-05	0.000625	CcSEcCtD
Mifepristone—Pruritus—Metformin—type 2 diabetes mellitus	8.86e-05	0.000623	CcSEcCtD
Mifepristone—Urticaria—Losartan—type 2 diabetes mellitus	8.84e-05	0.000621	CcSEcCtD
Mifepristone—Abdominal pain—Losartan—type 2 diabetes mellitus	8.79e-05	0.000618	CcSEcCtD
Mifepristone—Body temperature increased—Losartan—type 2 diabetes mellitus	8.79e-05	0.000618	CcSEcCtD
Mifepristone—Vomiting—Valsartan—type 2 diabetes mellitus	8.75e-05	0.000615	CcSEcCtD
Mifepristone—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	8.71e-05	0.000612	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	8.69e-05	0.000611	CcSEcCtD
Mifepristone—ABCB1—liver—type 2 diabetes mellitus	8.68e-05	0.00557	CbGeAlD
Mifepristone—Rash—Valsartan—type 2 diabetes mellitus	8.67e-05	0.00061	CcSEcCtD
Mifepristone—Dermatitis—Valsartan—type 2 diabetes mellitus	8.66e-05	0.000609	CcSEcCtD
Mifepristone—Vomiting—Orlistat—type 2 diabetes mellitus	8.64e-05	0.000607	CcSEcCtD
Mifepristone—Insomnia—Ramipril—type 2 diabetes mellitus	8.63e-05	0.000606	CcSEcCtD
Mifepristone—Headache—Valsartan—type 2 diabetes mellitus	8.62e-05	0.000606	CcSEcCtD
Mifepristone—Diarrhoea—Metformin—type 2 diabetes mellitus	8.57e-05	0.000602	CcSEcCtD
Mifepristone—Rash—Orlistat—type 2 diabetes mellitus	8.57e-05	0.000602	CcSEcCtD
Mifepristone—Dermatitis—Orlistat—type 2 diabetes mellitus	8.56e-05	0.000602	CcSEcCtD
Mifepristone—Headache—Orlistat—type 2 diabetes mellitus	8.51e-05	0.000599	CcSEcCtD
Mifepristone—Dyspnoea—Ramipril—type 2 diabetes mellitus	8.5e-05	0.000598	CcSEcCtD
Mifepristone—Asthenia—Irbesartan—type 2 diabetes mellitus	8.48e-05	0.000596	CcSEcCtD
Mifepristone—Somnolence—Ramipril—type 2 diabetes mellitus	8.48e-05	0.000596	CcSEcCtD
Mifepristone—Pruritus—Irbesartan—type 2 diabetes mellitus	8.36e-05	0.000588	CcSEcCtD
Mifepristone—Decreased appetite—Ramipril—type 2 diabetes mellitus	8.29e-05	0.000583	CcSEcCtD
Mifepristone—Dizziness—Metformin—type 2 diabetes mellitus	8.28e-05	0.000582	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	8.23e-05	0.000579	CcSEcCtD
Mifepristone—Fatigue—Ramipril—type 2 diabetes mellitus	8.22e-05	0.000578	CcSEcCtD
Mifepristone—Hypersensitivity—Losartan—type 2 diabetes mellitus	8.2e-05	0.000576	CcSEcCtD
Mifepristone—Nausea—Valsartan—type 2 diabetes mellitus	8.17e-05	0.000574	CcSEcCtD
Mifepristone—Constipation—Ramipril—type 2 diabetes mellitus	8.16e-05	0.000573	CcSEcCtD
Mifepristone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.09e-05	0.000569	CcSEcCtD
Mifepristone—Nausea—Orlistat—type 2 diabetes mellitus	8.07e-05	0.000568	CcSEcCtD
Mifepristone—Asthenia—Losartan—type 2 diabetes mellitus	7.98e-05	0.000561	CcSEcCtD
Mifepristone—Vomiting—Metformin—type 2 diabetes mellitus	7.96e-05	0.00056	CcSEcCtD
Mifepristone—Rash—Metformin—type 2 diabetes mellitus	7.9e-05	0.000555	CcSEcCtD
Mifepristone—Dermatitis—Metformin—type 2 diabetes mellitus	7.89e-05	0.000555	CcSEcCtD
Mifepristone—Pruritus—Losartan—type 2 diabetes mellitus	7.87e-05	0.000553	CcSEcCtD
Mifepristone—Feeling abnormal—Ramipril—type 2 diabetes mellitus	7.86e-05	0.000553	CcSEcCtD
Mifepristone—Headache—Metformin—type 2 diabetes mellitus	7.85e-05	0.000552	CcSEcCtD
Mifepristone—Dizziness—Irbesartan—type 2 diabetes mellitus	7.82e-05	0.000549	CcSEcCtD
Mifepristone—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7.8e-05	0.000548	CcSEcCtD
Mifepristone—Diarrhoea—Losartan—type 2 diabetes mellitus	7.61e-05	0.000535	CcSEcCtD
Mifepristone—Urticaria—Ramipril—type 2 diabetes mellitus	7.58e-05	0.000533	CcSEcCtD
Mifepristone—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.54e-05	0.00053	CcSEcCtD
Mifepristone—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.54e-05	0.00053	CcSEcCtD
Mifepristone—Vomiting—Irbesartan—type 2 diabetes mellitus	7.52e-05	0.000528	CcSEcCtD
Mifepristone—Rash—Irbesartan—type 2 diabetes mellitus	7.45e-05	0.000524	CcSEcCtD
Mifepristone—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.45e-05	0.000523	CcSEcCtD
Mifepristone—Nausea—Metformin—type 2 diabetes mellitus	7.44e-05	0.000523	CcSEcCtD
Mifepristone—Headache—Irbesartan—type 2 diabetes mellitus	7.4e-05	0.000521	CcSEcCtD
Mifepristone—Dizziness—Losartan—type 2 diabetes mellitus	7.36e-05	0.000517	CcSEcCtD
Mifepristone—Vomiting—Losartan—type 2 diabetes mellitus	7.07e-05	0.000497	CcSEcCtD
Mifepristone—Hypersensitivity—Ramipril—type 2 diabetes mellitus	7.03e-05	0.000494	CcSEcCtD
Mifepristone—Nausea—Irbesartan—type 2 diabetes mellitus	7.02e-05	0.000494	CcSEcCtD
Mifepristone—Rash—Losartan—type 2 diabetes mellitus	7.01e-05	0.000493	CcSEcCtD
Mifepristone—Dermatitis—Losartan—type 2 diabetes mellitus	7.01e-05	0.000493	CcSEcCtD
Mifepristone—Headache—Losartan—type 2 diabetes mellitus	6.97e-05	0.00049	CcSEcCtD
Mifepristone—Asthenia—Ramipril—type 2 diabetes mellitus	6.84e-05	0.000481	CcSEcCtD
Mifepristone—Pruritus—Ramipril—type 2 diabetes mellitus	6.75e-05	0.000474	CcSEcCtD
Mifepristone—Nausea—Losartan—type 2 diabetes mellitus	6.61e-05	0.000464	CcSEcCtD
Mifepristone—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.53e-05	0.000459	CcSEcCtD
Mifepristone—Dizziness—Ramipril—type 2 diabetes mellitus	6.31e-05	0.000443	CcSEcCtD
Mifepristone—Vomiting—Ramipril—type 2 diabetes mellitus	6.06e-05	0.000426	CcSEcCtD
Mifepristone—Rash—Ramipril—type 2 diabetes mellitus	6.01e-05	0.000423	CcSEcCtD
Mifepristone—Dermatitis—Ramipril—type 2 diabetes mellitus	6.01e-05	0.000422	CcSEcCtD
Mifepristone—Headache—Ramipril—type 2 diabetes mellitus	5.98e-05	0.00042	CcSEcCtD
Mifepristone—Nausea—Ramipril—type 2 diabetes mellitus	5.67e-05	0.000398	CcSEcCtD
Mifepristone—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	6.34e-06	0.000101	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	6.34e-06	0.000101	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—AGT—type 2 diabetes mellitus	6.32e-06	0.000101	CbGpPWpGaD
Mifepristone—ABCC1—Disease—INS—type 2 diabetes mellitus	6.31e-06	0.0001	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ADCY5—type 2 diabetes mellitus	6.31e-06	0.0001	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GPX1—type 2 diabetes mellitus	6.28e-06	0.0001	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP2E1—type 2 diabetes mellitus	6.26e-06	9.96e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.22e-06	9.9e-05	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	6.22e-06	9.89e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CALM1—type 2 diabetes mellitus	6.21e-06	9.88e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—APOE—type 2 diabetes mellitus	6.19e-06	9.85e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—SLC2A1—type 2 diabetes mellitus	6.19e-06	9.85e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP1A2—type 2 diabetes mellitus	6.19e-06	9.85e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	6.18e-06	9.82e-05	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—PPARG—type 2 diabetes mellitus	6.14e-06	9.77e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CD36—type 2 diabetes mellitus	6.12e-06	9.74e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—APOA1—type 2 diabetes mellitus	6.12e-06	9.73e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—AKT2—type 2 diabetes mellitus	6.1e-06	9.71e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	6.09e-06	9.68e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PPP2CA—type 2 diabetes mellitus	6.04e-06	9.61e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP3A4—type 2 diabetes mellitus	6.04e-06	9.6e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	6.03e-06	9.59e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.94e-06	9.45e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.94e-06	9.45e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GCG—type 2 diabetes mellitus	5.93e-06	9.44e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—SLC2A4—type 2 diabetes mellitus	5.93e-06	9.44e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	5.91e-06	9.4e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	5.91e-06	9.4e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	5.89e-06	9.37e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	5.89e-06	9.37e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	5.89e-06	9.37e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—SERPINE1—type 2 diabetes mellitus	5.8e-06	9.23e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—MTHFR—type 2 diabetes mellitus	5.8e-06	9.23e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	5.79e-06	9.22e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	5.76e-06	9.16e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	5.76e-06	9.16e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	5.76e-06	9.16e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	5.72e-06	9.1e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PPARA—type 2 diabetes mellitus	5.69e-06	9.05e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	5.68e-06	9.04e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	5.65e-06	8.99e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	5.65e-06	8.99e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	5.62e-06	8.94e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—RELA—type 2 diabetes mellitus	5.59e-06	8.9e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	5.57e-06	8.86e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	5.57e-06	8.86e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	5.55e-06	8.84e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NOS3—type 2 diabetes mellitus	5.54e-06	8.81e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3R1—type 2 diabetes mellitus	5.54e-06	8.81e-05	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—SERPINE1—type 2 diabetes mellitus	5.53e-06	8.8e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—AGT—type 2 diabetes mellitus	5.51e-06	8.77e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	5.46e-06	8.69e-05	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	5.45e-06	8.68e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	5.44e-06	8.65e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	5.44e-06	8.65e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	5.43e-06	8.63e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	5.43e-06	8.63e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	5.43e-06	8.63e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CALM1—type 2 diabetes mellitus	5.42e-06	8.62e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—APOE—type 2 diabetes mellitus	5.4e-06	8.59e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PPARG—type 2 diabetes mellitus	5.39e-06	8.58e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	5.39e-06	8.58e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	5.34e-06	8.5e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—APOA1—type 2 diabetes mellitus	5.34e-06	8.49e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	5.3e-06	8.42e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—INS—type 2 diabetes mellitus	5.29e-06	8.41e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	5.25e-06	8.35e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	5.25e-06	8.35e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	5.25e-06	8.35e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	5.23e-06	8.33e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	5.16e-06	8.21e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	5.16e-06	8.21e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	5.16e-06	8.21e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	5.11e-06	8.14e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.11e-06	8.14e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	5.09e-06	8.1e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	5.07e-06	8.06e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTGS2—type 2 diabetes mellitus	5.06e-06	8.06e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.04e-06	8.02e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	5.02e-06	7.99e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	5.02e-06	7.99e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	4.94e-06	7.85e-05	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	4.92e-06	7.83e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	4.92e-06	7.82e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	4.88e-06	7.76e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	4.87e-06	7.74e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	4.87e-06	7.74e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	4.87e-06	7.74e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ALB—type 2 diabetes mellitus	4.85e-06	7.71e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	4.78e-06	7.6e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.77e-06	7.58e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	4.74e-06	7.55e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	4.73e-06	7.53e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	4.72e-06	7.51e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.72e-06	7.5e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PPARG—type 2 diabetes mellitus	4.7e-06	7.48e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	4.67e-06	7.43e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	4.67e-06	7.43e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	4.66e-06	7.41e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—NOS3—type 2 diabetes mellitus	4.64e-06	7.38e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.64e-06	7.38e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	4.63e-06	7.37e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.62e-06	7.35e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—INS—type 2 diabetes mellitus	4.61e-06	7.34e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	4.56e-06	7.25e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	4.55e-06	7.25e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	4.54e-06	7.23e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	4.48e-06	7.12e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	4.48e-06	7.12e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.46e-06	7.1e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.46e-06	7.1e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.46e-06	7.1e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.46e-06	7.1e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	4.45e-06	7.08e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	4.42e-06	7.04e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	4.4e-06	7e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	4.4e-06	7e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SRC—type 2 diabetes mellitus	4.39e-06	6.99e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	4.37e-06	6.95e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	4.29e-06	6.83e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.28e-06	6.81e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.28e-06	6.81e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTGS2—type 2 diabetes mellitus	4.24e-06	6.75e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	4.23e-06	6.73e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	4.22e-06	6.71e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	4.22e-06	6.71e-05	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—AKT1—type 2 diabetes mellitus	4.2e-06	6.68e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	4.19e-06	6.67e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	4.11e-06	6.54e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—SRC—type 2 diabetes mellitus	4.1e-06	6.52e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	4.04e-06	6.43e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	4.04e-06	6.43e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	3.98e-06	6.34e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.98e-06	6.33e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.93e-06	6.25e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	3.92e-06	6.23e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	3.9e-06	6.21e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	3.86e-06	6.14e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.86e-06	6.14e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	3.86e-06	6.14e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.85e-06	6.13e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	3.84e-06	6.11e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	3.79e-06	6.03e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.72e-06	5.91e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	3.7e-06	5.89e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	3.68e-06	5.85e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TGFB1—type 2 diabetes mellitus	3.66e-06	5.83e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.64e-06	5.79e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.64e-06	5.79e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.64e-06	5.79e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	3.64e-06	5.79e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	3.62e-06	5.76e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EGFR—type 2 diabetes mellitus	3.59e-06	5.71e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	3.58e-06	5.69e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	3.57e-06	5.68e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.57e-06	5.68e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.55e-06	5.64e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.55e-06	5.64e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.55e-06	5.64e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.52e-06	5.61e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	3.51e-06	5.59e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	3.47e-06	5.52e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.46e-06	5.51e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	3.44e-06	5.47e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	3.43e-06	5.45e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.42e-06	5.44e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	3.4e-06	5.41e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	3.37e-06	5.37e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	3.34e-06	5.31e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	3.33e-06	5.3e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	3.31e-06	5.27e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.3e-06	5.24e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	3.24e-06	5.16e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	3.23e-06	5.14e-05	CbGpPWpGaD
Mifepristone—AR—Gene Expression—AKT1—type 2 diabetes mellitus	3.2e-06	5.09e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.18e-06	5.06e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.18e-06	5.06e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.18e-06	5.06e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	3.16e-06	5.03e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	3.15e-06	5e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.12e-06	4.97e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.11e-06	4.94e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	3.1e-06	4.94e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.09e-06	4.92e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	3.06e-06	4.86e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.03e-06	4.82e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	3.01e-06	4.78e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.98e-06	4.74e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL6—type 2 diabetes mellitus	2.96e-06	4.71e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	2.96e-06	4.7e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	2.94e-06	4.68e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.92e-06	4.65e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	2.92e-06	4.65e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	2.92e-06	4.65e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	2.91e-06	4.63e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.91e-06	4.63e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.88e-06	4.58e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.88e-06	4.58e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.83e-06	4.51e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.78e-06	4.43e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.78e-06	4.41e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—IL6—type 2 diabetes mellitus	2.76e-06	4.39e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.76e-06	4.39e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.76e-06	4.39e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.74e-06	4.36e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.73e-06	4.34e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	2.67e-06	4.25e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.57e-06	4.08e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—AKT1—type 2 diabetes mellitus	2.55e-06	4.05e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.52e-06	4e-05	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—AKT1—type 2 diabetes mellitus	2.43e-06	3.86e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.42e-06	3.85e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.38e-06	3.78e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.38e-06	3.78e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.37e-06	3.77e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.37e-06	3.77e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.34e-06	3.71e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.31e-06	3.67e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.27e-06	3.61e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.21e-06	3.51e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.21e-06	3.51e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.21e-06	3.51e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.17e-06	3.46e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.16e-06	3.44e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—AKT1—type 2 diabetes mellitus	2.13e-06	3.39e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.12e-06	3.37e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.11e-06	3.36e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.08e-06	3.31e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.08e-06	3.31e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.06e-06	3.27e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.03e-06	3.23e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	2.02e-06	3.21e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.95e-06	3.1e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.91e-06	3.04e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.9e-06	3.03e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	1.86e-06	2.96e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.85e-06	2.95e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.82e-06	2.9e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.81e-06	2.89e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.79e-06	2.85e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.58e-06	2.51e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.55e-06	2.47e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.42e-06	2.26e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.36e-06	2.16e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.36e-06	2.16e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.34e-06	2.14e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.24e-06	1.98e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.01e-06	1.61e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	9.56e-07	1.52e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	6.25e-07	9.94e-06	CbGpPWpGaD
